Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Altered glycosylation in inflammatory bowel disease: a possible role in cancer development.

Campbell BJ, Yu LG, Rhodes JM.

Glycoconj J. 2001 Nov-Dec;18(11-12):851-8. Review.

PMID:
12820718
2.

Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared.

Rhodes JM, Campbell BJ.

Trends Mol Med. 2002 Jan;8(1):10-6.

PMID:
11796261
3.

The lymphatic system controls intestinal inflammation and inflammation-associated Colon Cancer through the chemokine decoy receptor D6.

Vetrano S, Borroni EM, Sarukhan A, Savino B, Bonecchi R, Correale C, Arena V, Fantini M, Roncalli M, Malesci A, Mantovani A, Locati M, Danese S.

Gut. 2010 Feb;59(2):197-206. doi: 10.1136/gut.2009.183772. Epub 2009 Oct 20.

PMID:
19846409
5.

Chronic inflammatory bowel disease and cancer.

Pohl C, Hombach A, Kruis W.

Hepatogastroenterology. 2000 Jan-Feb;47(31):57-70. Review.

PMID:
10690586
7.

Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk?

Breynaert C, Vermeire S, Rutgeerts P, Van Assche G.

Acta Gastroenterol Belg. 2008 Oct-Dec;71(4):367-72. Review.

PMID:
19317276
8.
9.
11.

Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients.

Saeland E, Belo AI, Mongera S, van Die I, Meijer GA, van Kooyk Y.

Int J Cancer. 2012 Jul 1;131(1):117-28. doi: 10.1002/ijc.26354. Epub 2011 Nov 28.

12.

Colonic carcinogenesis in IBD: molecular events.

Pozza A, Scarpa M, Ruffolo C, Polese L, Erroi F, Bridda A, Norberto L, Frego M.

Ann Ital Chir. 2011 Jan-Feb;82(1):19-28.

PMID:
21657151
13.

Diagnostic problems and advances in inflammatory bowel disease.

Odze R.

Mod Pathol. 2003 Apr;16(4):347-58. Review.

14.

Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation.

Itzkowitz SH, Yio X.

Am J Physiol Gastrointest Liver Physiol. 2004 Jul;287(1):G7-17. Review.

15.
16.

The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics.

Linskens RK, Huijsdens XW, Savelkoul PH, Vandenbroucke-Grauls CM, Meuwissen SG.

Scand J Gastroenterol Suppl. 2001;(234):29-40. Review.

PMID:
11768558
17.

Cell surface-expressed Thomsen-Friedenreich antigen in colon cancer is predominantly carried on high molecular weight splice variants of CD44.

Singh R, Campbell BJ, Yu LG, Fernig DG, Milton JD, Goodlad RA, FitzGerald AJ, Rhodes JM.

Glycobiology. 2001 Jul;11(7):587-92.

PMID:
11447138
18.
19.

Activation of NF-kappaB in intestinal epithelial cells by E. coli strains isolated from the colonic mucosa of IBD patients.

La Ferla K, Seegert D, Schreiber S.

Int J Colorectal Dis. 2004 Jul;19(4):334-42. Epub 2004 Apr 22.

PMID:
15103488
20.

Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.

Triantafillidis JK, Nasioulas G, Kosmidis PA.

Anticancer Res. 2009 Jul;29(7):2727-37. Review.

Supplemental Content

Support Center